Details for New Drug Application (NDA): 017441
✉ Email this page to a colleague
NDA 017441 describes INFED, which is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. Additional details are available on the INFED profile page.
The generic ingredient in INFED is iron dextran. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the iron dextran profile page.
The generic ingredient in INFED is iron dextran. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the iron dextran profile page.
Summary for 017441
| Tradename: | INFED |
| Applicant: | Allergan |
| Ingredient: | iron dextran |
| Patents: | 0 |
Pharmacology for NDA: 017441
| Mechanism of Action | Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 017441
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| INFED | iron dextran | INJECTABLE;INJECTION | 017441 | NDA | Allergan, Inc. | 0023-6082 | 0023-6082-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0023-6082-10) / 2 mL in 1 VIAL, SINGLE-DOSE (0023-6082-01) |
| INFED | iron dextran | INJECTABLE;INJECTION | 017441 | NDA | Henry Schein, Inc. | 0404-9879 | 0404-9879-02 | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9879-02) / 2 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG IRON/2ML (EQ 50MG IRON/ML) | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | BP | RLD: | Yes | ||||
Complete Access Available with Subscription
